Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
The BRAFV600E gene encodes a mutant BRAFV600E protein that triggers downstream oncogenic signaling in thyroid cancer. As most currently available methods focus on detecting BRAFV600E mutations in tumor DNA, information on BRAFV600E mRNA levels in primary thyroid cancer tumors is limited, and the diagnostic relevance of these RNA mutations is unclear.